BioDelivery’s stock rockets toward a 2-year high after buyout deal with Collegium at a 54% premium

Shares of BioDelivery Sciences International Inc. BDSI, -1.62% blasted 51.7% higher to pace all premarket gainers Monday, after the specialty pharmaceutical company with a portfolio of pain and neurol...